VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,227,626 | -31.4% | 22,748,880 | 0.0% | 0.95% | -28.5% |
| Q2 2023 | $70,294,039 | -42.6% | 22,748,880 | 0.0% | 1.33% | -52.1% |
| Q1 2023 | $122,388,974 | -19.1% | 22,748,880 | 0.0% | 2.77% | -9.7% |
| Q4 2022 | $151,280,052 | +241.8% | 22,748,880 | +104.6% | 3.07% | +225.0% |
| Q3 2022 | $44,261,000 | -19.9% | 11,120,973 | 0.0% | 0.94% | -36.0% |
| Q2 2022 | $55,271,000 | -17.7% | 11,120,973 | 0.0% | 1.47% | +0.5% |
| Q1 2022 | $67,171,000 | -48.0% | 11,120,973 | 0.0% | 1.47% | -35.6% |
| Q4 2021 | $129,226,000 | -25.9% | 11,120,973 | 0.0% | 2.28% | -5.7% |
| Q3 2021 | $174,377,000 | -15.9% | 11,120,973 | 0.0% | 2.42% | -27.4% |
| Q2 2021 | $207,406,000 | -56.7% | 11,120,973 | 0.0% | 3.33% | -53.9% |
| Q1 2021 | $479,314,000 | – | 11,120,973 | – | 7.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $288,444,000 | 51.94% |
| Trustees of Columbia University in the City of New York | 183,821 | $7,923,000 | 9.60% |
| RA Capital Management | 11,120,973 | $479,314,000 | 7.23% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $46,318,000 | 6.00% |
| Sarissa Capital Management LP | 707,010 | $30,472,000 | 2.92% |
| SECTORAL ASSET MANAGEMENT INC | 535,259 | $23,070,000 | 1.75% |
| Woodline Partners LP | 1,153,267 | $49,706,000 | 1.10% |
| Artal Group S.A. | 550,000 | $23,705,000 | 0.42% |
| Orbimed Advisors | 833,333 | $35,917,000 | 0.34% |
| Laurion Capital Management LP | 585,667 | $25,242,000 | 0.14% |